Andreas Suhrbier

Title: Innovations and Contributions of Inventor Andreas Suhrbier

Introduction

Andreas Suhrbier is a notable inventor based in Bunya, Australia. He has made significant contributions to the field of medical treatments, particularly in addressing virally induced lesions and inflammatory conditions. With a total of nine patents to his name, Suhrbier's work has the potential to impact the lives of many individuals suffering from various skin conditions.

Latest Patents

One of Suhrbier's latest patents focuses on the treatment of virally induced lesions. This invention relates to the treatment of cutaneous lesions containing cells infected by a virus, specifically targeting lesions caused by the Human Papilloma Virus. The use of ingenol compounds, particularly ingenol angelates, is central to this innovation. Another significant patent involves the topical use of ingenol-3-angelate or its salts for treating skin cancer. This invention provides a chemical agent from the macrocyclic diterpene family, derived from the Euphorbiaceae family of plants, for the treatment and prophylaxis of inflammatory conditions in mammals, including humans.

Career Highlights

Throughout his career, Suhrbier has worked with reputable companies such as Leo Laboratories Limited and CSL Limited. His experience in these organizations has contributed to his expertise in developing innovative treatments for skin conditions.

Collaborations

Suhrbier has collaborated with notable individuals in his field, including James Harrison Aylward and Peter Gordon Parsons. These collaborations have likely enriched his research and development efforts.

Conclusion

Andreas Suhrbier's contributions to medical innovation, particularly in the treatment of skin conditions, highlight his role as a significant inventor. His patents reflect a commitment to improving health outcomes through scientific advancements.